Skip to content
Search

Latest Stories

Latest stats show a 20% rise in MS patient numbers

There is a 20 per cent increase in the estimated number of people in the UK living with multiple sclerosis (MS), according to latest figures.

The new data from Public Health England (PHE) and the MS Society, published today, shows that over 130,000 people in the country are now living with MS, compared to the 2018 estimate of 110,000.


The number of people with the condition in all four UK nations has increased, with Scotland seeing the biggest rise from 11,300 to 15,700.

The estimated number of new cases of MS identified each year also increased from 5,000 a year in 2018 to 6,700.

The figures reveal that one in every 500 people in the UK is living with MS, while about 130 people are diagnosed every week on average.

MS Society views the latest figures as confirmation of many more people living with the condition in the UK than previous estimates.

Dr Susan Kohlhaas, Director of Research and External Affairs at the MS Society, said: “While the NHS is getting better at diagnosing and recording cases of MS, unfortunately in many important ways society is getting worse at supporting people with the condition. Compared to just a few years ago, fewer people with MS receive social care support and key welfare payments – and we hear far too many stories of people struggling to stay in work without the adjustments they need.”

“MS is relentless, painful and disabling and people with the condition desperately need the Government to step up and create an expanded and sustainable social care system, overhaul the way benefits are assessed and strengthen rights for employee support,” Dr Kohlhaas added.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less